11 Oct 2025
Drug-coated balloons: a PREVAIL-ing gamechanger in complex PCI
Sponsored by Medtronic
Anchorperson:
J. W. C. Tan
Spokesperson:
G. H. Choo
Summary
Focus on the evolving role of drug-coated balloons (DCB) in complex PCI, extending their use beyond traditional indications to challenging coronary lesions and high-risk patient populations. This session reviews clinical data from the SCAAR Prevail registry and discusses the evidence journey supporting broader advocacy for DCB in bifurcations, ACS, STEMI, multivessel disease, diabetes, and calcified lesions.
Learning Objectives
- To drive discussion on the use of drug-coated balloons in complex coronary lesions and high-risk patient populations, including bifurcations, ACS, STEMI, multivessel disease, diabetes, and calcified lesions, expanding beyond traditional indications such as in-stent restenosis and small vessel disease
